UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):August 2, 2004
Paradigm Genetics, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other
jurisdiction of
incorporation) | | 0-30365
(Commission
File Number) | | 56-2047837
(IRS Employer
Identification No.) |
108 T.W. Alexander Drive, Research Triangle Park, North Carolina
(Address of principal executive offices) | | 27709
(Zip Code) |
Registrant’s telephone number, including area code:(919) 425-3000
Item 12. Disclosure of Results of Operations and Financial Condition.
The following exhibits are furnished with this report:
| Exhibit Number | Description |
| 99.1 | Press Release dated August 2, 2004. |
On August 2, 2004, the Registrant issued a press release to report its financial results for the quarter ended June 30, 2004. A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | Paradigm Genetics, Inc.
(Registrant) |
| Date: August 2, 2004 | /s/ Philip R. Alfano
Philip R. Alfano
Vice President, Finance and Chief Financial Officer |
EXHIBIT INDEX
Exhibit
Number
99.1 | |
Description
The Registrant’s Press Release dated August 2, 2004 | | Sequential
Page Number
5 |
